Recipients › Texas › Marker Therapeutics Inc
Recipient organisation · UEI CK3KR85CSP23
Marker Therapeutics Inc
USAspending caveat. Figures are obligations reported by federal agencies to USAspending.gov, not payments. In USAspending's words: "An outlay occurs when federal money is actually paid out, not just promised to be paid ('obligated')." "Every agency has a Senior Accountable Official who must officially certify that the quarterly financial data submitted by their agency is accurate and complete." "If there are any discrepancies in procurement data, FPDS is the authoritative source." Contract data for the Department of Defense and the U.S. Army Corps of Engineers is published with a 90-day delay. Data loaded 30 Sep 2026. View the USAspending recipient profile.
USAspending records $12M in award obligations to Marker Therapeutics Inc (Houston, TX) over the fiscal years it is listed for (2024, 2025, 2026).
In FY2026, the most recent complete fiscal year, obligations were $4.8M, with contracts under the listing floor.
That is up 37% on FY2025 ($3.5M).
Marker Therapeutics Inc ranks 1,277 of 1,510 listed organisations located in TX by five-year obligations, and 25,184 of 30,000 nationally.
Its $1.0M-plus awards since FY2023 came from Department of Health and Human Services and Department of Defense: 5 awards worth $12M in total award value.
Obligations by fiscal year contracts vs assistance
| Fiscal year | All obligations | Contracts | Assistance | Change |
|---|---|---|---|---|
| FY2023 | under $1.0M | — | — | — |
| FY2024 | $3,174,534 | under $1.0M | $3,174,534 | — |
| FY2025 | $3,541,289 | under $1.0M | $3,541,289 | +12% |
| FY2026 | $4,835,167 | under $1.0M | $4,835,167 | +37% |
| FY2027 to date | under $1.0M | — | — | — |
A fiscal year runs 1 October to 30 September. "Contracts" are procurement award types A–D; "assistance" is everything else (grants, direct payments, loan subsidy cost, insurance, other). The contracts column is listed only where contract obligations alone reached $1.0M; the assistance figure is the remainder and may therefore include up to $1.0M of contracts.
Compared with its state and the largest recipients five listed years
| Measure | This organisation | Largest in TX | Largest nationally |
|---|---|---|---|
| Five-year obligations (listed years) | $12M | $179B | $416B |
| FY2026 obligations | $4.8M | $46B | $118B |
| Contracts, five years | under $1.0M | under $1.0M | $94B |
| Assistance, five years | $12M | $179B | $416B |
| Rank by five-year obligations | 25,184 of 30,000 | 1 of 1,510 in TX | 1 |
Largest in state: Health & Human SVC COMMN TX. Largest nationally: Health Care Services, California Department of. Rankings count organisations located in the state, by the sum of their listed fiscal years.
Awarding agencies $1.0M+ awards since FY2023
| # | Agency | Awards | Award value | Share |
|---|---|---|---|---|
| 1 | Department of Health and Human Services | 4 | $7.3M | 64% |
| 2 | Department of Defense | 1 | $4.2M | 36% |
Assistance programs listings
Places of performance $1.0M+ awards
Counties: Harris County, TX $12M
Largest awards begun since FY2023
| Awarding agency | Type | Industry or program | Award value | Begun | Place | Record |
|---|---|---|---|---|---|---|
| Department of DefenseDefense Health Agency | GrantProject Grant (B) | 12.420 Military Medical Research and Development | $4.2M | 24 Jul 2026 | TX | USAspending |
| Department of Health and Human ServicesNational Institutes of Health | GrantProject Grant (B) | 93.395 Cancer Treatment Research | $2.0M | 14 Jun 2024 | TX | USAspending |
| Department of Health and Human ServicesNational Institutes of Health | GrantProject Grant (B) | 93.395 Cancer Treatment Research | $2.0M | 8 Aug 2024 | TX | USAspending |
| Department of Health and Human ServicesNational Institutes of Health | GrantProject Grant (B) | 93.395 Cancer Treatment Research | $2.0M | 8 Aug 2023 | TX | USAspending |
| Department of Health and Human ServicesNational Institutes of Health | GrantProject Grant (B) | 93.395 Cancer Treatment Research | $1.3M | 30 Aug 2024 | TX | USAspending |
Award value is the amount obligated to the award to date as USAspending reports it. Descriptions below are USAspending's text, unedited and truncated; those that appear to name a person are withheld.
- $4.2M, Department of Defense, 24 Jul 2026: GRANT, PHASE 2 TRIAL OF PATIENT-DERIVED MULTITUMOR-ASSOCIATED ANTIGEN-SPECIFIC T CELLS (MT-601) TO TREAT RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (DLBC
- $2.0M, Department of Health and Human Services, 14 Jun 2024: CONTROLLING TUMOR IMMUNE ESCAPE IN PANCREATIC CANCER USING A DUAL T CELL PRODUCT STRATEGY - ABSTRACT WHILE T CELL THERAPIES HAVE SHOWN EFFICACY IN HEMATOLOGIC M
- $2.0M, Department of Health and Human Services, 8 Aug 2024: A PHASE 1 STUDY OF PATIENT-DERIVED MULTI-TUMOR-ASSOCIATED ANTIGEN SPECIFIC T CELLS (MT-601) ADMINISTERED TO PATIENTS WITH RELAPSED NON-HODGKIN LYMPHOMA - ABSTRA
- $2.0M, Department of Health and Human Services, 8 Aug 2023: PHASE 2 CLINICAL TRIAL OF A NOVEL T CELL THERAPY FOLLOWING BRIDGING THERAPY WITH HYPOMETHYLATING AGENTS FOR RELAPSED AML PATIENTS POST-STEM CELL TRANSPLANT - AB
- $1.3M, Department of Health and Human Services, 30 Aug 2024: A PHASE 1 STUDY OF PATIENT-DERIVED MULTI-TUMOR ASSOCIATED ANTIGEN SPECIFIC T CELLS (MT-601) ADMINISTERED TO PATIENTS WITH METASTATIC PANCREATIC CANCER FOLLOWING
Questions and answers
How much federal money does Marker Therapeutics Inc receive?
$12M in award obligations over the fiscal years it is listed for (FY2024: $3.2M; FY2025: $3.5M; FY2026: $4.8M). Years not listed were under the $1.0M floor. Obligations are binding commitments, not payments made.
Which agencies award to Marker Therapeutics Inc?
By the value of $1.0M-plus awards begun since FY2023: Department of Health and Human Services ($7.3M) and Department of Defense ($4.2M).
What is the money for?
Assistance falls under Cancer Treatment Research (93.395) and Military Medical Research and Development (12.420).
Where is the work performed?
Primary places of performance for its larger awards: TX ($12M).
Is Marker Therapeutics Inc a large federal recipient?
It ranks 25,184 of 30,000 organisations on this site by five-year obligations and 1,277 of 1,510 located in TX. The site covers organisations with at least $1.0M in a fiscal year; individuals are excluded.
Where does this data come from?
USAspending.gov (U.S. Treasury), award transactions as loaded on 30 Sep 2026; fiscal-year totals via the spending-by-category endpoint and award lists via the award search endpoint. The USAspending recipient profile is the authoritative record.
Provenance
Source: USAspending.gov API v2 (U.S. Department of the Treasury, Bureau of the Fiscal Service), CC0. Fiscal-year obligations from the spending-by-category recipient ranking by recipient state (listing floor $1.0M per year); awards from the award search endpoint (new awards of $1.0M or more by base obligation date); parent and business categories from the recipient profile where fetched. Closed fiscal years are snapshots taken after year end; FY2027 is refreshed on each build. Data loaded by USAspending on 30 Sep 2026. Individuals and sole proprietors are excluded at ingest. Errors in processing are corrected at the next build; see corrections and the methodology.